Fujisawa Pharmaceutical (TSE: 4511) produces and markets pharmaceuticals, medical equipment and supplies, home care business, chemicals and animal health products. The company is one of Japan's largest drug makers, with its main strength in antibiotics. About 35 percent of sales come from overseas, much of which is from sales of its immunosuppressive agent Prograf.